Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial

Published 2013 View Full Article

Authors

Keywords

Journal

LANCET NEUROLOGY

Volume 12, Issue 11, Pages 1076-1083

Publisher

Elsevier BV

Online

2013-10-01

DOI

10.1016/s1474-4422(13)70227-8

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

LANCET NEUROLOGY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Add your recorded webinar

Ask a Question. Answer a Question.